Retinal Sensitivity in BRVO After Anti-VEGF Therapy

计划入组 50 人 · 首次发布于 2015 年 8 月 19 日

601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)

计划入组 60 人 · 首次发布于 2020 年 12 月 16 日

Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial

计划入组 82 人 · 首次发布于 2006 年 9 月 1 日

BRVT-121

BRVT-231

BRVT-321

Fakultní nemocnice Brno

Czech Republic

Fakultní nemocnice Brno - Dětská nemocnice

Czech Republic

St. Anne's University Hospital Brno

Czech Republic

Roche's Vabysmo Demonstrates Sustained Efficacy in Retinal Vein Occlusion with Extended Dosing Intervals

Chugai's Vabysmo Receives Japanese Approval for Retinal Vein Occlusion Treatment

Roche's Vabysmo Shows Sustained Vision Improvements with Extended Treatment Intervals in Retinal Vein Occlusion Studies